The predictive role of hematologic markers in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy: a retrospective cohort study

BACKGROUND: Neoadjuvant chemoimmunotherapy is an important therapeutic modality for resectable nonsmall cell lung cancer (NSCLC). The roles of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in predicting the efficacy and prognosis of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenliang, Ren, Siying, Yang, Lulu, Xiao, Ying, Zeng, Chao, Chen, Chen, Wu, Fang, Hu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651234/
https://www.ncbi.nlm.nih.gov/pubmed/37578441
http://dx.doi.org/10.1097/JS9.0000000000000650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651234/
https://www.ncbi.nlm.nih.gov/pubmed/37578441
http://dx.doi.org/10.1097/JS9.0000000000000650

Ejemplares similares